United States · FDA National Drug Code directory
Adempas
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-251_21ffd9c9-204f-4809-af50-5e6f26e9d4ce
- Product NDC
- 50419-251
- Form
- TABLET, FILM COATED
- Composition / generic term
- riociguat
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20131008
- Source listing expiry
- 20271231
Source-listed ingredients
- RIOCIGUAT — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, FILM COATED in 1 BOTTLE (50419-251-01) · 50419-251-01
- 2 BLISTER PACK in 1 PACKAGE (50419-251-03) / 21 TABLET, FILM COATED in 1 BLISTER PACK · 50419-251-03
- 90 TABLET, FILM COATED in 1 BOTTLE (50419-251-71) · 50419-251-71
- 9 TABLET, FILM COATED in 1 BOTTLE (50419-251-91) · 50419-251-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →